Clinical Significance of mTOR and p-mTOR Protein Expression in Human Colorectal Carcinomas

被引:0
|
作者
Wang, Di [1 ,2 ]
Chen, Jian [2 ]
Guo, Fengjie [2 ]
Chen, Hui [2 ]
Duan, Zhi [2 ]
Wei, Mei-Yan [2 ]
Xu, Qi-Mei [2 ]
Wang, Liang-Hua [2 ]
Zhong, Mei-Zuo [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Canc, Changsha, Hunan, Peoples R China
[2] First Hosp Changsha, Changsha, Hunan, Peoples R China
关键词
Colorectal cancer; mTOR; p-mTOR; immunohistochemistry; overexpession; MAMMALIAN TARGET; CANCER; RAPAMYCIN; PATHWAY; INHIBITOR; GROWTH; ACTIVATION; TUMORS; COLON; LUNG;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate the significance of mammalian target of rapamycin (mTOR) and its active form, p-mTOR in colorectal carcinomas. Methods: Immunohistochemistry was used to detect the expression of mTOR and p-mTOR proteins in 108, 40 and 40 tissue samples from colorectal carcinoma, normal colonic mucosa and adenomatous polyps samples, respectively. The correlation of mTOR and p-mTOR expression with clinicopathological characteristics of colorectal carcinoma was analyzed. Results: The positive rates of mTOR and p-mTOR were significantly higher in colorectal carcinoma (61.1% and 61.1%, respectively, p<0.05) than in normal colonic mucosa (7.5% and 2.5%) and adenomatous polyps (27.5% and 20%). Overexpression of total mTOR protein was significantly associated with T1/T2 stage tumors, lymph node metastasis, distal metastasis) and degree of differentiation. p-mTOR overexpression was additionaly linked with degree of differentiation and TNM stage. Conclusion: The overexpression of mTOR and p-mTOR may play important roles in colorectal carcinogenesis with relations to the degree of differentiation, invasiveness and metastasis.
引用
收藏
页码:2581 / 2584
页数:4
相关论文
共 50 条
  • [1] Expression of mammalian target of rapamycin (mTOR) and phosphorylated - mTOR (p-mTOR) in prostatic adenocarcinomas (PACs)
    Kallakury, B. V. S.
    Sheehan, G. M.
    Fisher, H. A. G.
    Kaufman, R. P., Jr.
    Ross, J. S.
    LABORATORY INVESTIGATION, 2008, 88 : 162A - 163A
  • [2] Expression of mammalian target of rapamycin (mTOR) and phosphorylated-mTOR (p-mTOR) in prostatic adenocarcinomas (PACs)
    Kallakury, B. V. S.
    Sheehan, G. M.
    Fisher, H. A. G.
    Kaufman, R. P., Jr.
    Ross, J. S.
    MODERN PATHOLOGY, 2008, 21 : 162A - 163A
  • [3] Roles of mTOR and p-mTOR in Gastrointestinal Stromal Tumors
    Li, Jun-Chuan
    Zhu, Hong-Yu
    Chen, Ting-Xuan
    Zou, Lan-Ying
    Wang, Xiao-Yan
    Zhao, Hui-Chuan
    Xu, Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 5925 - 5928
  • [4] Elevated phosphorylated mammalian target of rapamycin (p-mtor) expression in human neoplasms
    Ross, J. S.
    Qian, J.
    Sheehan, C.
    Jones, D.
    Jennings, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
    Qiu, Weiwei
    Ren, Meiying
    Wang, Cuifeng
    Fu, Yuhua
    Liu, Yan
    MEDICINE, 2022, 101 (51)
  • [6] Expression of mTOR protein and its clinical significance in endometrial cancer
    No, Jae Hong
    Jeon, Yong-Tark
    Park, In-Ae
    Kang, Daehee
    Kim, Jae Weon
    Park, Noh-Hyun
    Kang, Soon-Beom
    Song, Yong-Sang
    MEDICAL SCIENCE MONITOR, 2009, 15 (10): : BR301 - BR305
  • [7] Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma
    Li, Ning
    Sui, Jianfu
    Liu, Hao
    Zhong, Ming
    Zhang, Min
    Wang, Yan
    Hao, Fengyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 5236 - 5244
  • [8] P-mTOR Expression and Implication in Breast Carcinoma: A Systematic Review and MetaAnalysis
    Ding, Xian-Fei
    Li, Li-Feng
    Zhou, Xue-Liang
    Guo, Li-Na
    Dou, Meng-Meng
    Chi, Yan-Yan
    Wu, Shao-Xuan
    Zhang, Ya-Na
    Shan, Zheng-Zheng
    Zhang, Yi-Jie
    Wang, Feng
    Fan, Qing-Xia
    Zhao, Jie
    Sun, Tong-Wen
    PLOS ONE, 2017, 12 (01):
  • [9] Differential Expression of p-mTOR in Cutaneous Basal and Squamous Cell Carcinomas Likely Explains their Different Response to mTOR Inhibitors in Organ-transplant Recipients
    Karayannopoulou, Georgia
    Euvrard, Sylvie
    Kanitakis, Jean
    ANTICANCER RESEARCH, 2013, 33 (09) : 3711 - 3714
  • [10] Relation between outcomes and localisation of p-mTOR expression in gastric cancer
    Murayama, T.
    Inokuchi, M.
    Takagi, Y.
    Yamada, H.
    Kojima, K.
    Kumagai, J.
    Kawano, T.
    Sugihara, K.
    BRITISH JOURNAL OF CANCER, 2009, 100 (05) : 782 - 788